Podcast: Rethinking Osteoarthritis: Targeting Inflammation in Dogs With Dr. Tarantino
Monica Tarantino, DVM, MBA
Sponsored by Elanco
As our understanding of canine osteoarthritis deepens and treatment options continue to expand, there's never been a better opportunity to refine how we approach this disease in practice. In this episode of the Partner Podcast, Dr. Beth invites Dr. Monica Tarantino to explore what's actually happening in the arthritic joint, why inflammation deserves its own place in the treatment conversation, and how she navigates anti-inflammatory options in her senior patients.
Indication Galliprant controls pain and inflammation associated with osteoarthritis in dogs.
Important Safety Information For use in dogs only. Keep this and all medications out of reach of children and pets to prevent accidental ingestion or overdose. Galliprant is a non-COX inhibiting NSAID. As a class, NSAIDs may be associated with gastrointestinal, kidney and liver side effects. Evaluation for pre-existing conditions and regular monitoring are recommended. Do not use in dogs that have a hypersensitivity to grapiprant. Concomitant use of Galliprant with other NSAIDs or corticosteroids should be avoided. Concurrent use with other anti-inflammatory drugs or protein-bound drugs has not been studied. The safe use of Galliprant has not been evaluated in dogs younger than 9 months of age and less than 8 lbs (3.6 kg), dogs used for breeding, pregnant or lactating dogs, or dogs with cardiac disease. Owners should be advised to observe for signs of potential drug toxicity. Adverse reactions may include vomiting, diarrhea, decreased appetite, watery or bloody stools, and decreases in serum albumin and total protein. Click here for full prescribing information.
Contact us:
Podcast@instinct.vet
Where to find us:
Website:
YouTube:
Facebook:
LinkedIn:
Instagram:
The Team:
Beth Molleson, DVM - Host
Sarah Pate - Producer & Project Manager, Brief Studio
Taylor Argo- Podcast Production & Sound Editing
